Safety Shot, Inc.

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: US48208F1057
USD
0.20
0.03 (21.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

366.56 k

Shareholding (Mar 2025)

FII

0.45%

Held by 12 FIIs

DII

97.68%

Held by 3 DIIs

Promoter

0.00%

How big is Safety Shot, Inc.?

22-Jun-2025

As of Jun 18, Safety Shot, Inc. has a market capitalization of 20.90 million, with net sales of 1.04 million and a net profit of -38.06 million over the last four quarters. The company's shareholder's funds were -2.17 million, and total assets amounted to 7.34 million as of Dec 24.

Market Cap: As of Jun 18, Safety Shot, Inc. has a market capitalization of 20.90 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Safety Shot, Inc. reported net sales of 1.04 million and a net profit of -38.06 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds were -2.17 million, and total assets amounted to 7.34 million.

Read More

What does Safety Shot, Inc. do?

22-Jun-2025

Safety Shot, Inc. is a wellness company focused on developing hemp-derived cannabidiol (CBD) consumer products, with a market cap of USD 20.90 million. As of March 2025, it reported net sales of USD 0 million and a net profit loss of USD 5 million.

Overview: <BR>Safety Shot, Inc. is a wellness hemp-derived cannabidiol (CBD) consumer product development company operating in the FMCG industry with a market cap of USD 20.90 Million.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -5 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 20.90 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -4.70 <BR>Return on Equity: 3,720.17% <BR>Price to Book: -20.90<BR><BR>Contact Details: <BR>Address: 725 N. HWY A1A, SUITE C-106, JUPITER FL : 33458 <BR>Tel: 1 561 3250482 <BR>Website: https://jupiterwellnessinc.com/

Read More

Should I buy, sell or hold Safety Shot, Inc.?

22-Jun-2025

Who are in the management team of Safety Shot, Inc.?

22-Jun-2025

As of March 2022, the management team of Safety Shot, Inc. includes Dr. Glynn Wilson (Chairman and Head of R&D), Mr. Brian John (CEO), Mr. Richard Miller (COO), and several independent directors: Dr. Hector Alila, Mr. Timothy Glynn, Mr. Christopher Melton, and Mr. Byron Young. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Safety Shot, Inc. includes the following individuals:<BR><BR>- Dr. Glynn Wilson, who serves as the Chairman of the Board and Head of Research and Development.<BR>- Mr. Brian John, the Chief Executive Officer and a Director.<BR>- Mr. Richard Miller, the Chief Operating Officer and a Director.<BR>- Dr. Hector Alila, an Independent Director.<BR>- Mr. Timothy Glynn, an Independent Director.<BR>- Mr. Christopher Melton, an Independent Director.<BR>- Mr. Byron Young, an Independent Director. <BR><BR>This team is responsible for the strategic direction and operational management of the company.

Read More

Is Safety Shot, Inc. overvalued or undervalued?

20-Sep-2025

As of August 14, 2025, Safety Shot, Inc. is deemed overvalued and not a viable investment due to negative financial metrics, including a Price to Book Value of -20.94, while its peers show more favorable valuations.

As of 14 August 2025, the valuation grade for Safety Shot, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its financial standing. The company appears to be overvalued given its negative valuation metrics, including a Price to Book Value of -20.94, an EV to EBIT of -0.79, and an EV to EBITDA of -0.80. These figures suggest that the company is struggling to generate positive earnings and is not a viable investment at its current price.<BR><BR>In comparison to its peers, Safety Shot, Inc. shows a stark contrast; for instance, Nu Skin Enterprises, Inc. has a P/E ratio of 5.47 and an EV to EBITDA of 8.64, highlighting a more favorable valuation. Additionally, Grove Collaborative Holdings, Inc. is categorized as risky with an EV to EBITDA of -4.96, further emphasizing the challenges faced by Safety Shot, Inc. Without available return data, it is difficult to assess the company's performance against the S&P 500, but the overall financial metrics suggest that it is not positioned well in the market.

Read More

Is Safety Shot, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, Safety Shot, Inc. has shifted to a mildly bearish trend, indicated by bearish MACD signals and Bollinger Bands, while underperforming the S&P 500 with a 1-year return of -80.04%.

As of 12 September 2025, the technical trend for Safety Shot, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by bearish signals from the MACD on both weekly and monthly time frames, and a bearish indication from the Bollinger Bands on the monthly chart. The Dow Theory presents a mixed view with a mildly bearish weekly signal and a mildly bullish monthly signal. The stock has significantly underperformed compared to the S&P 500 across multiple periods, with a 1-year return of -80.04% versus the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 0%

  • The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2

Poor long term growth as Operating profit has grown by an annual rate -272.71% of over the last 5 years

 
3

Negative results in Jun 25

4

Risky - Negative EBITDA

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

FMCG

stock-summary
Market cap

USD 66 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.36

stock-summary
Return on Equity

-146.15%

stock-summary
Price to Book

2.86

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
13 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-51.48%
0%
-51.48%
6 Months
-22.86%
0%
-22.86%
1 Year
-78.74%
0%
-78.74%
2 Years
-95.88%
0%
-95.88%
3 Years
-82.32%
0%
-82.32%
4 Years
-81.64%
0%
-81.64%
5 Years
-95.31%
0%
-95.31%

Safety Shot, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.36%
EBIT Growth (5y)
-272.71%
EBIT to Interest (avg)
-15.11
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-4.70
Sales to Capital Employed (avg)
0.36
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.43%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-20.94
EV to EBIT
-0.79
EV to EBITDA
-0.80
EV to Capital Employed
6.16
EV to Sales
24.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-782.57%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (1.87%)

Foreign Institutions

Held by 12 Foreign Institutions (0.45%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -100.00% vs -70.83% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 261.45% vs -1,975.00% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.70",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.20",
          "val2": "-8.30",
          "chgp": "49.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "18.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.40",
          "val2": "-8.30",
          "chgp": "261.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-96,547.90%",
          "val2": "-11,845.20%",
          "chgp": "-8,470.27%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 250.00% vs 100.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -227.03% vs 5.13% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.70",
          "val2": "0.20",
          "chgp": "250.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-41.60",
          "val2": "-12.40",
          "chgp": "-235.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.90",
          "val2": "-2.40",
          "chgp": "62.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-48.40",
          "val2": "-14.80",
          "chgp": "-227.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-59,914.00%",
          "val2": "-62,166.70%",
          "chgp": "225.27%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.70
-100.00%
Operating Profit (PBDIT) excl Other Income
-4.20
-8.30
49.40%
Interest
0.10
0.10
Exceptional Items
18.20
0.00
Consolidate Net Profit
13.40
-8.30
261.45%
Operating Profit Margin (Excl OI)
-96,547.90%
-11,845.20%
-8,470.27%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -100.00% vs -70.83% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 261.45% vs -1,975.00% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.70
0.20
250.00%
Operating Profit (PBDIT) excl Other Income
-41.60
-12.40
-235.48%
Interest
0.20
0.20
Exceptional Items
-0.90
-2.40
62.50%
Consolidate Net Profit
-48.40
-14.80
-227.03%
Operating Profit Margin (Excl OI)
-59,914.00%
-62,166.70%
225.27%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 250.00% vs 100.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -227.03% vs 5.13% in Dec 2023

stock-summaryCompany CV
About Safety Shot, Inc. stock-summary
stock-summary
Safety Shot, Inc.
FMCG
Jupiter Wellness, Inc. is a wellness hemp-derived cannabidiol (CBD), consumer product development company. The Company is engaged in manufacturing, distributing and marketing of consumer products infused with CBD. The Company’s brands include CaniSun, CaniSkin and CaniDermRX. Under the CaniSun brand, the Company is marketing three CBD-infused sun care lotion formulas containing various sun protection factors (SPFs). The CaniSun brand products include CBD-infused SPF 30 Lip Balm, CBD-infused SPF 15 sunscreen lotion and Mineral-based sunscreen lotions. Under the CaniDermRX brand, the Company is exploring a formulation of CBD with over-the-counter (OTC), consumer products that have potential therapeutic and medical applications. The CaniDermRX topical solution for the treatment of eczema dermatitis is the lead product candidate.
Company Coordinates stock-summary
Company Details
725 N. HWY A1A, SUITE C-106 , JUPITER FL : 33458
Registrar Details